Bookmark
Forward
Cardellino A, Correll JR, Martin M, Gorsh B, Sapra S, Popat R
Frontiers in oncology 2023
No tags found.
No abstract available.
Citation
Cardellino A, Correll JR, Martin M, Gorsh B, Sapra S, Popat R. Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study. Frontiers in oncology. 2023;13:1274659
PMID: 0
View Full Text
